Clinical Trial Update: Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia [NA]

View source ↗

Summary

A completed clinical trial assessing the effect of gemigliptin on metabolic endotoxemia and lipemia in individuals with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Gemigliptin (gemigliptin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED